All indicators (1192)


Malaria confirmed cases ratio

  Malaria
Confirmed malaria cases by total malaria cases (clinical and confirmed).
    

IPT2 utilization

  Antenatal
Percentage of clients receiving IPT1 also receiving IPT 2. IPT2/IPT1 x 100%
    

Low birth weight rate (% live births <2500g)

  Safe Delivery
The rate of live births that have low birth weight (under 2500g).
    

Low birth weight rate (% live births <2500g)

  Essential Services Indicators
The rate of live births that have low birth weight (under 2500g).
    

Patients started on ARVs

  ART services
    
    

Enrolled and eligible but not started on ART

  HIV care and treatment-MOH 711
    
    
    

DPT/Hep+HiB3 dropout rate

  Immunisation
The rate of children immunised for DPT1 (Penta 1) not turning up for DPT3 (Penta 3).
    

DPT/Hep+HiB3 dropout rate

  NVIP Scorecard
The rate of children immunised for DPT1 (Penta 1) not turning up for DPT3 (Penta 3).
    

Measles-rubella dropout rate

  Immunisation
The rate of DPT3 immunized children not turning up for Measles (all under 1 year). A negative rate means more children are immunized for Measles than DPT3. Measures performance of the EPI program.
    

Measles-rubella dropout rate

  NVIP Scorecard
The rate of DPT3 immunized children not turning up for Measles (all under 1 year). A negative rate means more children are immunized for Measles than DPT3. Measures performance of the EPI program.
    

HIV+ pregnant women received ARV for PMTCT

  Integrated Scorecard
Percentage of HIV-infected pregnant women who received antiretroviral prophylaxis for PMTCT
    

HIV+ pregnant women received ARV for PMTCT

  BNA_GroupWork
Percentage of HIV-infected pregnant women who received antiretroviral prophylaxis for PMTCT
    

HIV+ pregnant women received ARV for PMTCT

  BNA Tracer Indicators
Percentage of HIV-infected pregnant women who received antiretroviral prophylaxis for PMTCT
    

HIV+ test rate - PMTCT-Maternity

  MOH731-2 PMTCT
No. of advanced HIV infections newly enrolled.
    

HIV+ test rate - PMTCT-Maternity

  HIV tests
No. of advanced HIV infections newly enrolled.
    
    

Total deliveries in facilities

  Safe Delivery
Total deliveries as the sum of deliveries normal and complicated reported on 711
    

Caesarean section rate

  Safe Delivery
Percentage of deliveries that were through caesarean sections
    

Still birth rate

  Safe Delivery
    

Still birth rate

  BNA_GroupWork
    

PMTCT updake among ANC clients

  MOH731-2 PMTCT
Of all the new ANC clients, how many are tested for HIV (%).
    

HIV+ - PMTCT-ANC Prevalence

  MOH731-2 PMTCT
Of all the ANC clients tested for HIV, how many test are positive (%).
    

HIV+ - PMTCT-ANC Prevalence

  HIV tests
Of all the ANC clients tested for HIV, how many test are positive (%).
    

Family Planning New Cases

  Family Planning
    

Family Planning New Cases

  Family Planning Attendance
    

Family Planning Revisits

  Family Planning
    

Family Planning Revisits

  Family Planning Attendance
    

BCG Wastage Rate

  Logistics
Opening stock + Received Stock -balance stock- Children Vaccinated=Doses Wasted Divide by Opening stock + Received Stock
    

Measles Wastage Rate

  Logistics
Opening stock +Received stock -Stock balance -Children vaccinated= Wastage Divide by Total vaccines received
    

OPV Wastage Rate

  Logistics
Opening Stock+Received Stock-Balance in stock-Total children vaccinated=Wastage Divide by Total vaccines received in stock
    

DPT/HIB/HEP B Wastage Rate

  Logistics
Opening Stock+Received stock-Balance Stock - Children vaccinated=Wastage Divide By Total Vaccine received in stock
    
    
    

Pneumococal Wastage Rate (WR)

  Immunization Logistics
    
    
    
    

Vitamin A Wastage Rate

  Logistics
Opening stock +received Stock-Balance stock -doses given = Wastage Divide by Opening stock +Received Stock
    
    
    
    
    
    
    

Extra Pulmonary TB

  TB Services
    

TB Re-treatment rate

  TB Services
    
    

TB curative Rate

  TB Services
Smear -ve at the end of treatment /Total evaluated
    

Percentage Bed Occupancy

  Hospital Administrative
OBD / ABD* 100
    

Percentage Bed Occupancy

  Inpatient
OBD / ABD* 100
    

Bed Occupancy Rate

  Inpatient
    

Bed Occupancy Rate

  Essential Services Indicators
    

Available Bed Days - Medical Ward Male

  Hospital Administrative
    

Total number of children under 5 years who are weighed

  Child Health
Total number of Children under five years who are weighed during growth monitoring
    
    
    
    
    
    
    
    

HIV+ test rate - PMTCT -ANC

  MOH731-2 PMTCT
    

HCT Couples Discordancy Rate-MOH731

  FP Commodities Couple Year Protection
[HV01-09] / [HV01-05]
    

PMTCT Positivity at ANC

  MOH731-2 PMTCT
([HV02-05] + [HV02-06]) / [Integrated RH, HIVAIDS, Malaria, TB & Nutrition: ANC / PMTCT; New ANC clients]
    

PMTCT Positivity at ANC

  Integrated Scorecard
([HV02-05] + [HV02-06]) / [Integrated RH, HIVAIDS, Malaria, TB & Nutrition: ANC / PMTCT; New ANC clients]
    

PMTCT ARV Prophylaxis Rate (Mother)

  MOH731-2 PMTCT
[HV02-17] / [HV02-09]
    

PMTCT ARV Prophylaxis Rate (Mother)

  RMNCAH SCORECARD
[HV02-17] / [HV02-09]
    

PMTCT ARV Prophylaxis Rate (Infant)

  MOH731-2 PMTCT
[??????? ] / [HV02-32]
    

PMTCT ARV Prophylaxis Rate (Infant)

  RMNCAH SCORECARD
[??????? ] / [HV02-32]
    

PMTCT ARV Prophylaxis Rate (Infant)

  Integrated Scorecard
[??????? ] / [HV02-32]
    

PMTCT ARV Prophylaxis Rate (Infant)

  Scorecard Indicators
[??????? ] / [HV02-32]
    

PMTCT ARV Prophylaxis Rate (Infant)

  BNA Tracer Indicators
[??????? ] / [HV02-32]
    

PMTCT Prophylaxis Ratio - NVP Only

  MOH731-2 PMTCT
[HV02-13] / [HV02-17]
    

PMTCT Prophylaxis Ratio - (AZT+SdNVP)

  MOH731-2 PMTCT
[HV02-14] / [HV02-17]
    

PMTCT Prophylaxis Ratio - Interrupted HAART

  ART services
[HV02-15] / [HV02-17]
    

PMTCT Prophylaxis Ratio - Interrupted HAART

  MOH731-2 PMTCT
[HV02-15] / [HV02-17]
    

PMTCT Prophylaxis Ratio - Treatment HAART (ART)

  ART services
[HV02-16] / [HV02-17]
    

PMTCT Prophylaxis Ratio - Treatment HAART (ART)

  MOH731-2 PMTCT
[HV02-16] / [HV02-17]
    

PMTCT Positivity Infants

  MOH731-2 PMTCT
[HV02-32] / [HV02-28]
    

PMTCT Positivity Infants

  Integrated Scorecard
[HV02-32] / [HV02-28]
    

PMTCT Positivity Infants

  BNA Tracer Indicators
[HV02-32] / [HV02-28]
    

PMTCT (EBF + ERF) Rate

  MOH731-2 PMTCT
([HV02-33] + [HV02-34]) / [HV02-36]
    

PMTCT (EBF + ERF) Rate

  Integrated Scorecard
([HV02-33] + [HV02-34]) / [HV02-36]
    

PMTCT MF Rate

  MOH731-2 PMTCT
[HV02-35] / [HV02-36]
    

PMTCT MF Rate

  Integrated Scorecard
[HV02-35] / [HV02-36]
    

C&T Proportion receiving CTX

  MOH731
[HV03-07] / [HV03-19]
    

C&T ART Retention Rate

  ART services
[HV03-46] / [HV03-45]
    

C&T ART Retention Rate

  MOH731
[HV03-46] / [HV03-45]
    

C&T ART Retention Rate

  Integrated Scorecard
[HV03-46] / [HV03-45]
    

C&T ART Retention Rate

  BNA_GroupWork
[HV03-46] / [HV03-45]
    

C&T ART Retention Rate

  BNA Tracer Indicators
[HV03-46] / [HV03-45]
    

C&T TB Screening Rate

  MOH731
[HV03-54] / [HV03-73]
    

PEP Sexual Assault

  Integrated Scorecard
[HV05-10] + [HV05-11]
    
    
    

HIV+ test rate - VCT

  HIV tests
Percentage of HIV+ tests among total tested for HIV at VCT.
    

HIV+ test rate - DTC outpatients

  HIV tests
Percentage of HIV+ tests among total tests at DTC outpatient.
    

HIV+ test rate - DTC inpatients

  HIV tests
Percentage of HIV+ tests among total HIV tests at DTC inpatients.
    

WRA ANC Receiving Iron

  Nutrition Indicators
    

WRA ANC Receiving folate

  Nutrition Indicators
    
    
    
    
    
    
    
    
    
    

Fresh still Birth Rate

  Safe Delivery
    

Fresh still Birth Rate

  BNA_GroupWork
    

Fresh still Birth Rate

  BNA Tracer Indicators
    
    
    

Number of Women of reproductive age (WRA) receiving family planning (FP) commodities

  Family Planning
Number of Women of reproductive age (WRA) receiving family planning (FP) commodities
    

Number of Women of reproductive age (WRA) receiving family planning (FP) commodities

  Scorecard Indicators
Number of Women of reproductive age (WRA) receiving family planning (FP) commodities
    

Number of Women of reproductive age (WRA) receiving family planning (FP) commodities

  Draft Kenya RMNCAH Scorecard
Number of Women of reproductive age (WRA) receiving family planning (FP) commodities
    
    
    
    
    

TB cases detected Total

  TB Services
    

TB cases detected Total

  Essential Services Indicators
    

Smear positive TB Total

  TB Services
    

Smear negative TB Total

  TB Services
    
    
    
    

Deaths and discharges Total

  Service Workload
    
    

OPD attendance - total male (717)

  Out Patient
Total OPD attendance for male. Based on MoH 717, service workload data.
    

OPD attendance - total male (717)

  Service Workload
Total OPD attendance for male. Based on MoH 717, service workload data.
    
    
    

Male Condom Dispensed

  FP Commodities DIspensed
    

Female Condom Dispensed

  FP Commodities DIspensed
    

Emergency Pill Dispensed

  FP Commodities DIspensed
    

IUCD Copper T Dispensed

  FP Commodities DIspensed
    

Implants Dispensed

  FP Commodities DIspensed
    

Injectables Dispensed

  FP Commodities DIspensed
    

Progestin only Pills Dispensed

  FP Commodities DIspensed
    

Combined contraceptive Pills Dispensed

  FP Commodities DIspensed
    

Combined Contraceptive Pills Ending Balance

  FP Commodities Ending Balance
    

Emergency Pills Ending Balance

  FP Commodities Ending Balance
    

Female Condom Ending Balance

  FP Commodities Ending Balance
    

Implants Ending Balance

  FP Commodities Ending Balance
    

Injectables Ending Balance

  FP Commodities Ending Balance
    

IUCD Copper T Ending Balance

  FP Commodities Ending Balance
    

Male Condom Ending Balance

  FP Commodities Ending Balance
    

Progestin only Pills Ending Balance

  FP Commodities Ending Balance
    

IP - Average Length of Stay

  IP Ward Level
Average number of days a patient stays in the inpatient ward. Based on ward-level data from hospitals and other inpatient facilities. The type of ward providing the service is indicated by the orgunit capturing the data.
    

IP - Turn over interval

  IP Ward Level
Average number of days a bed remains vacant between discharge and admission to the bed during a period. Based on ward-level data from hospitals. The type of ward providing the service is indicated by the orgunit capturing the data.
    

IP - Crude Death Rate

  IP Ward Level
Number of deaths per admissions. Based on ward-level data from hospitals and other inpatient facilities. The type of ward providing the service is indicated by the orgunit capturing the data.
    

IP - Vacant Beds

  IP Ward Level
Average number of beds vacant per day. Based on ward-level data from hospitals and other inpatient facilities. The type of ward providing the service is indicated by the orgunit capturing the data.
    

PNC Attendance 1st Visit

  Integrated Scorecard
    

PNC Attendance 1st Visit

  Post Natal Care
    
    
    
    
    

ANC Partners Tested among New ANC Clients Coverage

  HSSF Coverage and Performance
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    

Stabilisation Center death rate - Nutrition

  Nutrition Indicators
This indicator monitors the number of deaths in the inpatient IMAM programme against the sphere standards
    
    

OTP Recovery Rate- Nutrition

  Nutrition Indicators
    

OTP Recovery Rate- Nutrition

  Nutrition Indicator Scorecard
    

OTP Death Rate- Nutrition

  Nutrition Indicators
    

OTP Default rate - Nutrition

  Nutrition Indicators
    

OTP Default rate - Nutrition

  Nutrition Indicator Scorecard
    

SFP Death Rate- Nutrition 6-59 months

  Nutrition Indicators
    
    
    

SFP Default Rate- Nutrition 6-59months

  Nutrition Indicator Scorecard
    
    
    
    
    
    
    
    

Percentage of Children under 5 years attending Child Welfare Clinics for growth monitoring for the first time in the calendar year

  Child Health
Number of Children under 5 years attending Child Welfare Clinics for growth monitoring (new cases)
    

Percentage of Children under 5 years attending Child Welfare Clinics for growth monitoring for the first time in the calendar year

  Nutrition Indicators
Number of Children under 5 years attending Child Welfare Clinics for growth monitoring (new cases)
    

Percentage of Children under 5 years attending Child Welfare Clinics for growth monitoring for the first time in the calendar year

  Nutrition Indicator Scorecard
Number of Children under 5 years attending Child Welfare Clinics for growth monitoring (new cases)
    

Available Bed Days= Medical Ward Female

  Hospital Administrative
    

Available Bed Days= Maternity ward

  Hospital Administrative
    

Available Bed Days= Labour Ward

  Hospital Administrative
    

Available Bed Days= paediatric ward

  Hospital Administrative
    

ALOS-Medical ward Male

  Hospital Administrative
    

ALOS-Medical ward Female

  Hospital Administrative
    

Available Bed Days= Nursery/Newborn Ward

  Hospital Administrative
    

Available Bed Days -Surgical Ward

  Hospital Administrative
    

Available Bed Days -Surgical Ward Male

  Hospital Administrative
    

Available Bed Days -Surgical Ward Female

  Hospital Administrative
    

Available Bed Days -Gynaecology Ward

  Hospital Administrative
    

ALOS-Maternity Ward

  Hospital Administrative
    

Available Bed Days -Orthopaedic ward

  Hospital Administrative
    

Available Bed Days -Isolation ward

  Hospital Administrative
    

ALOS-Labour Ward

  Hospital Administrative
    

ALOS-Paediatric Ward

  Hospital Administrative
    

Available Bed Days -Psychatric ward

  Hospital Administrative
    

Available Bed Days -Amenity Ward

  Hospital Administrative
    

ALOS-Nursery/Neonatal Ward

  Hospital Administrative
    

ALOS-Surgical Ward

  Hospital Administrative
    

ALOS-Surgical Female

  Hospital Administrative
    

ALOS-Surgical Male

  Hospital Administrative
    

ALOS-Gynacology Ward

  Hospital Administrative
    

ALOS-Orthopaedic Ward

  Hospital Administrative
    

ALOS-Isolation Ward

  Hospital Administrative
    

ALOS-Psychastric Ward

  Hospital Administrative
    

ALOS-Eye Ward

  Hospital Administrative
    

Available Bed Days -Eye Ward

  Hospital Administrative
    
    
    

Total <5years who are Underweight

  Nutrition Indicators
    

Total New <5years who are weight

  Nutrition Indicators
    

Total <5years who are Stunted

  Nutrition Indicators
    

Total Cildren 6-59Months Issued Vit A

  Nutrition Indicators
    
    
    

Total PTB- case tested for HIV

  TB Case FInding
    

Total PTB- case tested HIV +

  TB Case FInding
    

Total EPTB case tested for HIV

  TB Case FInding
    

Total EPTB case tested HIV +

  TB Case FInding
    
    

Total TB case tested HIV +

  TB Case FInding
    
    
    
    
    

PTB+ out of total TB cases

  TB Case FInding
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    

PTB+ HIV+ out of Tested PTB+

  TB Case FInding
    
    
    
    
    
    
    
    
    
    
    
    

Total Male All New PTB+ Tested

  TB Case FInding
    

Total Male All New PTB+ HIV+

  TB Case FInding
    

Total Female All New PTB+ HIV+

  TB Case FInding
    
    
    
    
    

Total TB cases detected

  TB Services
    

Total Female MDR DR TB cases

  TB Case FInding
    

Total Female MDR DR TB cases

  MDR Indicators
    
    
    
    
    

Total Male Mono DR TB cases

  TB Case FInding
    
    
    
    
    
    
    
    
    
    
    

Total New PTB- Male

  TB Case FInding
    

Total New PTB- Female

  TB Case FInding
    
    
    

Total New EPTB Male

  TB Case FInding
    

Total New EPTB Female

  TB Case FInding
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    

Total tested for HIV (PTB+)

  TB Case FInding
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    

Total tested for HIV (PTB-)

  TB Case FInding
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    

Total tested for HIV (EPTB)

  TB Case FInding
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    

Number MDR-TB tested for HIV

  MDR Indicators
    

Number MDR-TB tested HIV+

  MDR Indicators
    
    

Total PDR TB tested for HIV

  TB Case FInding
    

Total PDR TB tested HIV+

  TB Case FInding
    

Total MDR TB tested for HIV

  TB Case FInding
    

Total MDR TB tested for HIV

  MDR Indicators
    

Total MDR TB tested HIV+

  TB Case FInding
    

Total MDR TB tested HIV+

  MDR Indicators
    
    
    
    
    

Proportion of Maternal death audited

  Safe Delivery
Proportion of maternal deaths reviewed
    

Proportion of Maternal death audited

  Draft Kenya RMNCAH Scorecard
Proportion of maternal deaths reviewed
    
    

Malaria positivity rate (MEW)

  Malaria Early Warning Data (MEWs)
Malaria positivity rate (Malaria Early Warning)
    

% Blind due to Cataract

  Ophthalmic Services
    

% Blind due to Glaucoma

  Ophthalmic Services
    
    

% Diabetes screened

  Ophthalmic Services
    

% Diabetes screened

  BNA Tracer Indicators
    

Total Entropion Surgeries

  Ophthalmic Services
    

Total Ophthalmia Neonatorum

  Ophthalmic Services
    

Total Retinoblastoma

  Ophthalmic Services
    

Total Purulent Conjunctivitis

  Ophthalmic Services
    

Total Injury eye

  Ophthalmic Services
    

Total children with squint

  Ophthalmic Services
    

% Diabetic Retinopathy

  Ophthalmic Services
    

Cataract Adult >16 years

  Ophthalmic Services
    

Cataract operation 5-16 years

  Ophthalmic Services
    

Cataract <5 Years

  Ophthalmic Services
    

Glaucoma

  Ophthalmic Services
    

% Entropion surgery

  Ophthalmic Services
    

% Squint Surgery

  Ophthalmic Services
    

% Retinal Laser Treatment

  Ophthalmic Services
    
    
    
    
    
    
    
    

Total women tested(NASCOP)

  PMTCT_NASCOP
ANC tests plus Maternity tests
    
    
    
    
    
    

Total number of Patients starting ARVs

  ART services
Total number of patients starting ARVs by WHO stages
    

Total number of Patients starting ARVs

  HIV care and treatment-MOH 711
Total number of patients starting ARVs by WHO stages
    

Number of eligible HIV clients on ARVs

  HIV care and treatment-MOH 711
All patients currently on ARVs(pregnant women and others)
    

Proportion of clients starting ART

  ART services
New clients starting ART divided by total patients on ART
    

Proportion of clients starting ART

  HIV care and treatment-MOH 711
New clients starting ART divided by total patients on ART
    

Proportion of clients starting ART

  Integrated Scorecard
New clients starting ART divided by total patients on ART
    

Total number of new clients enrolled in HIV care

  HIV care and treatment-MOH 711
    

Total number of new clients enrolled in HIV care

  Essential Services Indicators
    

Total number of patients currently on ARVs(731)

  MOH731
All the totals for females and males by age group
    

Total number currently on Cotrimoxazole

  MOH731
Total number of clients currently on CTX according on age groups
    

Total number currently on Care

  MOH731
All on care
    
    
    

Cohort analysis

  MOH731
Retention at 12 months
    
    

%Mothers who received PMTCT ARVs

  HEI Cohort Analysis
    

%Mothers who received PMTCT ARVs

  Integrated Scorecard
    

%Mothers who received PMTCT ARVs

  BNA Tracer Indicators
    
    
    
    
    
    
    
    
    
    
    

% Active in follow‐up

  HEI Cohort Analysis
    
    
    

% Missing 9 month follow‐up visit

  HEI Cohort Analysis
    

% Died between 0 and 9 months

  HEI Cohort Analysis
    
    
    

% AB negative at 18 months

  HEI Cohort Analysis
    
    
    
    
    

% Died between 0 and 18 months

  HEI Cohort Analysis
    
    
    

Total BCG doses stocked in the month

  Immunization Logistics
    

Total OPV doses stocked in the month

  Immunization Logistics
    
    
    

Total Measle doses stocked in the month

  Immunization Logistics
    
    
    
    
    
    

Number of inpatients (admissions) Under 5

  Service Workload
Number of inpatients (admissions) Under 5
    

Number of inpatient (admissions) Over 5

  Service Workload
Number of inpatient (admissions) Over 5
    

XXXXX

  Service Workload
    

XXXXX

  Service Workload
    
    
    

EAC ANC first visit

  EAC OHI DE
    

EAC ANC first visit

  Integrated Scorecard
    

EAC ANC first visit

  Essential Services Indicators
    
    

EAC ANC fourth visit

  EAC OHI DE
    

EAC ANC fourth visit

  Integrated Scorecard
    

EAC ANC HIV test done

  EAC OHI DE
    
    
    
    
    
    
    
    
    
    

EAC Deliveries by skilled birth attendants

  Essential Services Indicators
    
    
    

EAC Delivery Expected

  EAC OHI DE
    
    
    
    
    
    

EAC Implants inserted

  EAC OHI DE
    

EAC IUD Inserted

  EAC OHI DE
    

EAC Live birth

  EAC OHI DE
    
    

EAC Malaria Admission

  EAC OHI DE
    
    

EAC Malaria Death

  EAC OHI DE
    
    
    
    
    
    
    

EAC PNC before 7 days

  EAC OHI DE
    

EAC PNC before 7 days

  Integrated Scorecard
    
    
    
    
    
    

EAC Stillbirths

  EAC OHI DE
    
    

EAC Vitamin A dose administered

  Integrated Scorecard
    

EAC Vitamin A dose administered

  Scorecard Indicators
    

EAC Vitamin A dose administered

  Essential Services Indicators
    
    

EAC Population Total

  EAC OHI DE
    

iHRIS Total Number of Nurses

  iHRIS Human Resources Indicators
This is the total of Nurses as provided by iHRIS
    

iHRIS Total Number of Clinical Officers

  iHRIS Human Resources Indicators
iHRIS Total Number of Clinical Officers
    

iHRIS Total Number of Doctors

  iHRIS Human Resources Indicators
Total Number of doctors from iHRIS
    

IHRIS Total Key Care Cadres

  iHRIS Human Resources Indicators
IHRIS Total Key Care Cadres - doctors, Nurses, Clinical Ofifcers
    
    
    
    

Infants below 6 months on exclusive breastfeeding

  Essential Services Indicators
    
    
    

Total Infant below 6 month exclusive breastfeed

  Essential Services Indicators
    

Number of  Maternal deaths audited

  Integrated Scorecard
    

Total Children Weight 0-6 Months

  Nutrition Indicators
    

Total Children attending CWC

  Nutrition Indicators
    
    
    
    
    
    
    

TB_FCDRR-Ending Bal_TB Patient Packs

  TB_ FCDRR Ending Balance
    
    

TB_FCDRR_ Ending Bal _R/H/E 150/75/275 mg

  TB_ FCDRR Ending Balance
    

TB_FCDRR_ Ending Bal _R/H 150/75 mg

  TB_ FCDRR Ending Balance
    

TB_FCDRR_Ending Bal _R/H/Z 60/30/150 mg

  TB_ FCDRR Ending Balance
    
    

TB_FCDRR_Ending Bal _R/H/Z 75/50/150 mg

  TB_ FCDRR Ending Balance
    

TB_FCDRR_Ending Bal _R/H 75/50 mg

  TB_ FCDRR Ending Balance
    
    

TB_FCDRR_Ending Bal _R/H 60/30 mg

  TB_ FCDRR Ending Balance
    
    

TB_FCDRR_Ending Bal _R/H 60/60 mg

  TB_ FCDRR Ending Balance
    

TB_FCDRR_Ending Bal _Ethambutol 100 mg

  TB_ FCDRR Ending Balance
    

TB_FCDRR_Ending Bal _Ethambutol 400 mg

  TB_ FCDRR Ending Balance
    

TB_FCDRR_Ending Bal _Pyrazinamide 500mg

  TB_ FCDRR Ending Balance
    

TB_FCDRR_Ending Bal _Rifampicin 300mg

  TB_ FCDRR Ending Balance
    

TB_FCDRR-Ending Bal_Omeprazole 20mg

  TB_ FCDRR Ending Balance
    

TB_FCDRR-Ending Bal_Fluoxetine 20mg

  TB_ FCDRR Ending Balance
    

TB_FCDRR-Ending Bal_Carbamazepine 200mg

  TB_ FCDRR Ending Balance
    
    

TB_FCDRR-Ending Bal_Benzhexol 5mg

  TB_ FCDRR Ending Balance
    

TB_FCDRR-Ending Bal_Haloperidol 5mg

  TB_ FCDRR Ending Balance
    
    

TB_FCDRR-Ending Bal_Amiloride 5mg

  TB_ FCDRR Ending Balance
    

TB_FCDRR-Ending Bal_Spironolactone 50mg

  TB_ FCDRR Ending Balance
    

TB_FCDRR-Ending Bal_Spironolactone 25mg

  TB_ FCDRR Ending Balance
    

TB_FCDRR-Ending Bal_Prednisolone 5mg

  TB_ FCDRR Ending Balance
    
    

TB_FCDRR-Ending Bal_Granisentron 3mg inj

  TB_ FCDRR Ending Balance
    

TB_FCDRR-Ending Bal_Granisentron 3mg

  TB_ FCDRR Ending Balance
    

TB_FCDRR-Ending Bal_Capreomycin 1gm vial

  TB_ FCDRR Ending Balance
    

TB_FCDRR-Ending Bal_Kanamycin 1gm vial

  TB_ FCDRR Ending Balance
    
    
    
    

TB_FCDRR-Ending Bal_Prothionamide 250mg

  TB_ FCDRR Ending Balance
    

TB_FCDRR-Ending Bal_Bedaquiline 100mg

  TB_ FCDRR Ending Balance
    

TB_FCDRR-Ending Bal_Linezolid 600mg

  TB_ FCDRR Ending Balance
    

TB_FCDRR-Ending Bal_Delaminid 50mg

  TB_ FCDRR Ending Balance
    

TB_FCDRR-Ending Bal_Clofazimine 100mg

  TB_ FCDRR Ending Balance
    
    

TB_FCDRR-Ending Bal_MB Adult Blister

  TB_ FCDRR Ending Balance
    

TB_FCDRR-Ending Bal_MB Child Blister Packs

  TB_ FCDRR Ending Balance
    

TB_FCDRR-Ending Bal_PB Adult Blister Packs

  TB_ FCDRR Ending Balance
    

TB_FCDRR-Ending Bal_PB Child Blister Packs

  TB_ FCDRR Ending Balance
    

TB_FCDRR-Ending Bal_Isoniazid 300mg

  TB_ FCDRR Ending Balance
    

TB_FCDRR-Ending Bal_Isoniazid 100mg

  TB_ FCDRR Ending Balance
    
    
    

TB_FCDRR-Ending Bal_Pyridoxine 25mg

  TB_ FCDRR Ending Balance
    

TB_FCDRR-Ending Bal_Pyridoxine 50mg

  TB_ FCDRR Ending Balance
    

TB_FCDRR-Qty for resupply_TB Patient Packs

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_R/H/Z/E 150/75/400/275 mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_R/H/E 150/75/275 mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_R/H 150/75 mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_R/H/Z 60/30/150 mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_R/H/Z 75/50/150 mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_R/H 75/50 mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_R/H 60/30 mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_R/H 60/60 mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Ethambutol 100 mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Ethambutol 400 mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Pyrazinamide 500mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Rifampicin 300mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Isoniazid 300mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Isoniazid 100mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Isoniazid Syrup 50mg /5ml

  TB_FCDRR quantity required for resupply
    
    

TB_FCDRR-Qty for resupply_Pyridoxine 25mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Pyridoxine 50mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_MB Adult Blister

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_MB Child Blister Packs

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_PB Adult Blister Packs

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_PB Child Blister Packs

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Capreomycin 1gm vial

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Kanamycin 1gm vial

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Cycloserine 250mg Tablets

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Levofloxacin 250mg Tablets

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Levofloxacin 500mg Tablets

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Prothionamide 250mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Bedaquiline 100mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Linezolid 600mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Delaminid 50mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Clofazimine 100mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Para-aminosalicylic acid 4mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Omeprazole 20mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Fluoxetine 20mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Carbamazepine 200mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Valproic acid (Sodium valproate) 200mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Benzhexol 5mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Haloperidol 5mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Magnesium Tricilicate 500mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Amiloride 5mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Spironolactone 50mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Spironolactone 25mg

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Prednisolone 5mg

  TB_FCDRR quantity required for resupply
    
    

TB_FCDRR-Qty for resupply_Granisentron 3mg inj

  TB_FCDRR quantity required for resupply
    

TB_FCDRR-Qty for resupply_Granisentron 3mg

  TB_FCDRR quantity required for resupply
    

TB_SCDRR-Ending Bal_TB Patient Packs

  TB_SCDRR Ending Balance
    
    

TB_SCDRR-Ending Bal_R/H/E 150/75/275 mg

  TB_SCDRR Ending Balance
    

TB_SCDRR-Ending Bal_R/H 150/75 mg

  TB_SCDRR Ending Balance
    

TB_SCDRR-Ending Bal_R/H/Z 60/30/150 mg

  TB_SCDRR Ending Balance
    

TB_SCDRR-Qty for resupply_TB Patient Packs

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_R/H/Z/E 150/75/400/275 mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Ending Bal_R/H/Z 75/50/150 mg

  TB_SCDRR Ending Balance
    

TB_SCDRR-Qty for resupply_R/H/E 150/75/275 mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Ending Bal_R/H 75/50 mg

  TB_SCDRR Ending Balance
    

TB_SCDRR-Ending Bal_R/H 60/30 mg

  TB_SCDRR Ending Balance
    

TB_SCDRR-Ending Bal_R/H 60/60 mg

  TB_SCDRR Ending Balance
    

TB_SCDRR-Ending Bal_Ethambutol 100 mg

  TB_SCDRR Ending Balance
    

TB_SCDRR-Ending Bal_Ethambutol 400 mg

  TB_SCDRR Ending Balance
    

TB_SCDRR-Ending Bal_Pyrazinamide 500mg

  TB_SCDRR Ending Balance
    

TB_SCDRR-Ending Bal_Rifampicin 300mg

  TB_SCDRR Ending Balance
    

TB_SCDRR-Ending Bal_Isoniazid 300mg

  TB_SCDRR Ending Balance
    

TB_SCDRR-Ending Bal_Isoniazid 100mg

  TB_SCDRR Ending Balance
    
    

TB_SCDRR-ending bal Prothionamide 250mg

  TB_SCDRR Ending Balance
    

TB_SCDRR-ending bal Bedaquiline 100mg

  TB_SCDRR Ending Balance
    

TB_SCDRR-ending bal Linezolid 600mg

  TB_SCDRR Ending Balance
    

TB_SCDRR-ending bal Delaminid 50mg

  TB_SCDRR Ending Balance
    

TB_SCDRR-ending bal Clofazimine 100mg

  TB_SCDRR Ending Balance
    
    

TB_SCDRR-ending bal soniazid 300mg

  TB_SCDRR Ending Balance
    

TB_SCDRR-ending bal Isoniazid 100mg

  TB_SCDRR Ending Balance
    
    
    

TB_SCDRR-ending bal Pyridoxine 25mg

  TB_SCDRR Ending Balance
    

TB_SCDRR-ending bal Pyridoxine 50mg

  TB_SCDRR Ending Balance
    

TB_SCDRR-ending bal MB Adult Blister

  TB_SCDRR Ending Balance
    

TB_SCDRR-ending bal MB Child Blister Packs

  TB_SCDRR Ending Balance
    

TB_SCDRR-ending bal PB Adult Blister Packs

  TB_SCDRR Ending Balance
    

TB_SCDRR-ending bal PB Child Blister Packs

  TB_SCDRR Ending Balance
    

TB-Omeprazole 20mg SoH

  TB_Stock on hand (SoH)
    

TB-Patient Packs SoH

  TB_Stock on hand (SoH)
    

TB_R/H/Z/E 150/75/400/275 mg SoH

  TB_Stock on hand (SoH)
    

TB-Fluoxetine 20mg SoH

  TB_Stock on hand (SoH)
    

TB-Carbamazepine 200mg SoH

  TB_Stock on hand (SoH)
    
    

TB_R/H/E 150/75/275 mg SoH

  TB_Stock on hand (SoH)
    

TB-Benzhexol 5mg SoH

  TB_Stock on hand (SoH)
    

TB-Haloperidol 5mg SoH

  TB_Stock on hand (SoH)
    

TB-Magnesium Tricilicate 500mg SoH

  TB_Stock on hand (SoH)
    

TB_R/H 150/75 mg SoH

  TB_Stock on hand (SoH)
    

TB_Amiloride 5mg SoH

  TB_Stock on hand (SoH)
    

TB_Spironolactone 50mg SoH

  TB_Stock on hand (SoH)
    

Tb_R/H/Z 60/30/150 mg SOH

  TB_Stock on hand (SoH)
    

TB_Spironolactone 25mg SoH

  TB_Stock on hand (SoH)
    

TB_Prednisolone 5mg SoH

  TB_Stock on hand (SoH)
    
    

TB_Granisentron 3mg inj SoH

  TB_Stock on hand (SoH)
    

TB_Granisentron 3mg SoH

  TB_Stock on hand (SoH)
    

TB_MB Adult Blister SoH

  TB_Stock on hand (SoH)
    

TB_MB Child Blister Packs SoH

  TB_Stock on hand (SoH)
    

TB_PB Adult Blister Packs SoH

  TB_Stock on hand (SoH)
    

TB_PB Child Blister Packs SoH

  TB_Stock on hand (SoH)
    

TB_Isoniazid 300mg SoH

  TB_Stock on hand (SoH)
    

TB-R/H/Z 75/50/150 mg SoH

  TB_Stock on hand (SoH)
    

TB-R/H 75/50 mg SoH

  TB_Stock on hand (SoH)
    

TB_R/H 60/30 mg SOH

  TB_Stock on hand (SoH)
    

TB-R/H 60/60 mg SoH

  TB_Stock on hand (SoH)
    

TB-Ethambutol 100 mg SoH

  TB_Stock on hand (SoH)
    

TB-Ethambutol 400 mg SoH

  TB_Stock on hand (SoH)
    

TB-Pyrazinamide 500mg SoH

  TB_Stock on hand (SoH)
    

TB-Rifampicin 300mg SoH

  TB_Stock on hand (SoH)
    

TB-Capreomycin 1gm vial SoH

  TB_Stock on hand (SoH)
    

TB_Isoniazid 100mg SoH

  TB_Stock on hand (SoH)
    

TB-Kanamycin 1gm vial SoH

  TB_Stock on hand (SoH)
    

TB_Isoniazid Syrup 50mg /5ml SoH

  TB_Stock on hand (SoH)
    

TB-Cycloserine 250mg Tablets SoH

  TB_Stock on hand (SoH)
    

TB-Levofloxacin 250mg Tablets SoH

  TB_Stock on hand (SoH)
    
    

TB_Pyridoxine 25mg SoH

  TB_Stock on hand (SoH)
    

TB_Pyridoxine 50mg SoH

  TB_Stock on hand (SoH)
    

TB_SCDRR-Qty for resupply_R/H 150/75 mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_R/H/Z 60/30/150 mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_R/H/Z 75/50/150 mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_R/H 75/50 mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_R/H 60/30 mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_R/H 60/60 mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Ethambutol 100 mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Ethambutol 400 mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Pyrazinamide 500mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Rifampicin 300mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Isoniazid 300mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Isoniazid 100mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Isoniazid Syrup 50mg /5ml

  TB_SCDRR quantity required for resupply
    
    

TB_SCDRR-Qty for resupply_Pyridoxine 25mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Pyridoxine 50mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_MB Adult Blister

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_MB Child Blister Packs

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_PB Adult Blister Packs

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_PB Child Blister Packs

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Capreomycin 1gm vial

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Kanamycin 1gm vial

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Cycloserine 250mg Tablets

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Levofloxacin 250mg Tablets

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Levofloxacin 500mg Tablets

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Prothionamide 250mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Bedaquiline 100mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Linezolid 600mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Delaminid 50mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Clofazimine 100mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Para-aminosalicylic acid 4mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Omeprazole 20mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Fluoxetine 20mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Carbamazepine 200mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Valproic acid (Sodium valproate) 200mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Benzhexol 5mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Haloperidol 5mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Magnesium Tricilicate 500mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Amiloride 5mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Spironolactone 50mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Spironolactone 25mg

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Prednisolone 5mg

  TB_SCDRR quantity required for resupply
    
    

TB_SCDRR-Qty for resupply_Granisentron 3mg inj

  TB_SCDRR quantity required for resupply
    

TB_SCDRR-Qty for resupply_Granisentron 3mg

  TB_SCDRR quantity required for resupply
    

TB-Levofloxacin 500mg Tablets SoH

  TB_Stock on hand (SoH)
    

TB-Prothionamide 250mg SoH

  TB_Stock on hand (SoH)
    

TB-Bedaquiline 100mg SoH

  TB_Stock on hand (SoH)
    

TB-Linezolid 600mg SoH

  TB_Stock on hand (SoH)
    

TB-Delaminid 50mg SoH

  TB_Stock on hand (SoH)
    

TB-Clofazimine 100mg SoH

  TB_Stock on hand (SoH)
    

TB-Para-aminosalicylic acid 4mg SoH

  TB_Stock on hand (SoH)
    

TB_TB Patient Packs MoS

  TB_Months of Stock (MoS)
    

TB_R/H/E 150/75/275 mg MoS

  TB_Months of Stock (MoS)
    
    
    
    
    

MOH 730_Abacavir (ABC) 300mg SoH

  MOH 730_Stock on Hand (SoH)
    
    

MOH 730_Efavirenz (EFV) 600mg Tabs SoH

  MOH 730_Stock on Hand (SoH)
    

MOH 730_Lamivudine (3TC) 150mg SoH

  MOH 730_Stock on Hand (SoH)
    

MOH 730_Lopinavir/ritonavir (LPV/r) 200/50mg SoH

  MOH 730_Stock on Hand (SoH)
    

MOH 730_Nevirapine (NVP) 200mg SoH

  MOH 730_Stock on Hand (SoH)
    

MOH 730_Tenofovir (TDF) 300mg SoH

  MOH 730_Stock on Hand (SoH)
    

MOH 730_Darunavir (DRV) 600mg SoH

  MOH 730_Stock on Hand (SoH)
    

MOH 730_Etravirine (ETV) 200mg SoH

  MOH 730_Stock on Hand (SoH)
    

MOH 730_Raltegravir (RAL) 400mg SoH

  MOH 730_Stock on Hand (SoH)
    

MOH 730_Ritonavir (RTV) 100mg SoH

  MOH 730_Stock on Hand (SoH)
    
    
    
    

MOH 730_Efavirenz (EFV) 200mg Tabs SoH

  MOH 730_Stock on Hand (SoH)
    

MOH 730_Lamivudine (3TC) liquid 10mg/ml SoH

  MOH 730_Stock on Hand (SoH)
    
    

MOH 730_Nevirapine (NVP) Susp 10mg/ml SoH

  MOH 730_Stock on Hand (SoH)
    

MOH 730_Darunavir (DRV) 150mg Tabs SoH

  MOH 730_Stock on Hand (SoH)
    

MOH 730_Darunavir (DRV) 75mg Tabs SoH

  MOH 730_Stock on Hand (SoH)
    

MOH 730_Darunavir (DRV) susp 100mg/ml SoH

  MOH 730_Stock on Hand (SoH)
    

MOH 730_Etravirine (ETV) 100mg tabs SoH

  MOH 730_Stock on Hand (SoH)
    

MOH 730_Etravirine (ETV) 25mg tabs SoH

  MOH 730_Stock on Hand (SoH)
    

MOH 730_Raltegravir (RAL) 100mg tabs SoH

  MOH 730_Stock on Hand (SoH)
    

MOH 730_Raltegravir (RAL) 25mg tabs SoH

  MOH 730_Stock on Hand (SoH)
    

MOH 730_Ritonavir (RTV) liquid 80mg/ml SoH

  MOH 730_Stock on Hand (SoH)
    
    
    

MOH 730_Cotrimoxazole Suspension 240mg/5ml SoH

  MOH 730_Stock on Hand (SoH)
    
    
    

MOH 730_Fluconazole 200mg Tabs SoH

  MOH 730_Stock on Hand (SoH)
    

MOH 730_Amphotericin B 50mg IV Injection SoH

  MOH 730_Stock on Hand (SoH)
    

MOH 730_Acyclovir 400mg Tabs SoH

  MOH 730_Stock on Hand (SoH)
    

MOH 730_Pyridoxine 50mg Tabs SoH

  MOH 730_Stock on Hand (SoH)
    

MOH 730_Pyridoxine 25mg Tabs SoH

  MOH 730_Stock on Hand (SoH)
    
    
    

MOH 730_Isoniazid (H) 100mg tabs SoH

  MOH 730_Stock on Hand (SoH)
    

MOH 729B Total - Adult ART Patients

  MOH 729 ART
MOH 729B Total - Adult ART Patients
    

MOH 729B Total - Adult PEP

  MOH 729 ART
MOH 729B Total - Adult PEP
    

MOH 729B Total - PMTCT - Women

  MOH 729 ART
MOH 729B Total - PMTCT - Women
    

MOH 729B Total - Paediatric ART

  MOH 729 ART
MOH 729B Total - Paediatric ART
    

MOH 729B Total - Paediatric PEP

  MOH 729 ART
MOH 729B Total - Paediatric PEP
    

MOH 729B Total - Paediatric PMTCT (Infants)

  MOH 729 ART
MOH 729B Total - Paediatric PMTCT
    

MOH 729B Total - OIs Universal prophylaxis

  MOH 729 ART
MOH 729B Total - OIs Universal prophylaxis
    

MOH 729B Total - OIs IPT

  MOH 729 ART
MOH 729B Total - OIs IPT
    

MOH 729B Total ART Patients

  MOH 729 ART
MOH 729B Total ART Patients
    
    
    

MOH 729B Adult OIs Universal prophylaxis

  MOH 729 ART
MOH 729B Adult OIs Universal prophylaxis
    

MOH 729B Paediatric - OIs Universal prophylaxis

  MOH 729 ART
MOH 729B Paediatric - OIs Universal prophylaxis
    
    
    
    
    
    
    
    
    
    

Total BCG doses used in the month

  Immunization Logistics
    

Total BCG doses wasted in the month

  Immunization Logistics
    

BCG Wastage Rate (WR)

  Immunization Logistics
    

Total OPV doses used in the month

  Immunization Logistics
    

Total OPV doses wasted in the month

  Immunization Logistics
    

OPV Wastage Rate (WR)

  Immunization Logistics
    

Total IPV doses stocked in the month

  Immunization Logistics
    

Total IPV doses used in the month

  Immunization Logistics
    

Total IPV doses wasted in the month

  Immunization Logistics
    

IPV Wastage Rate (WR)

  Immunization Logistics
    
    

DPT+HIB+HEP B Wastage Rate (WR)

  Immunization Logistics
    
    
    
    
    
    
    
    
    
    
    
    
    
    

Funds utilization rate Scorecard

  Facility Score card
    
    

Total Admissions (MOH 717)

  Service Workload
    

Malaria Commodities Results Positive Total

  Malaria Commodities
Malaria Commodities Results Positive Total
    

Malaria Commodities Results Negative Total

  Malaria Commodities
Malaria Commodities Results Negative Total
    

Malaria Commodities Results Total Tests(Microscopy)

  Malaria Commodities
Malaria Commodities Results Total Tests(Microscopy)
    

Malaria Commodities Results Total Tests(RDT)

  Malaria Commodities
Malaria Commodities Results Total Tests(RDT)
    

Malaria Commodities Results Total Tests

  Malaria Commodities
Malaria Commodities Results Total Tests
    

Malaria Percentage Positive Rate

  Malaria Commodities
Malaria Percentage Positive
    

Malaria Percentage Negative Rate

  Malaria Commodities
Malaria Percentage Negative Rate
    

Number of Pregnant Women receiving TT2 Plus immunization

  Immunisation
Number of Pregnant Women receiving TT2 Plus immunization
    

Total TB cases notified to the national program.

  TB Case Finding Revision 2016
    

Bacteriologically confirmed TB cases

  TB Case Finding Revision 2016
Number TB cases with a positive result through smear microscopy, culture or Xpert MTB/RIF that were notified.
    

Total (Pulmonary, clinically diagnosed)

  TB Case Finding Revision 2016
Total (Pulmonary, clinically diagnosed)
    

Total EPTB cases notified

  TB Case Finding Revision 2016
Total (Extra pulmonary, bacteriological confirmed / clinically diagnosed )
    

IDSR Cholera Cases

  IDSR Indicators
    

IDSR Cholera Deaths

  IDSR Indicators
    

IDSR Dysentry Total

  IDSR Indicators
    

IDSR Measles Total

  IDSR Indicators
    

IDSR Typhoid Total

  IDSR Indicators
    
    

IDSR Plague Total

  IDSR Indicators
    

IDSR Plague Deaths

  IDSR Indicators
    

IDSR Yellow Fever Total

  IDSR Indicators
    

IDSR Yellow Fever Deaths

  IDSR Indicators
    
    
    

IDSR Neonatal Tetanus Total

  IDSR Indicators
    

IDSR Neonatal Tetanus Deaths

  IDSR Indicators
    

AEFI Total

  IDSR Indicators
    

AEFI Deaths

  IDSR Indicators
    

IDSR Acute Jaundice Cases

  IDSR Indicators
    

IDSR Acute Jaundice Deaths

  IDSR Indicators
    

IDSR Acute Malnutrition Cases

  IDSR Indicators
    

IDSR Acute Malnutrition Deaths

  IDSR Indicators
    

IDSR Anthrax Cases

  IDSR Indicators
    

IDSR Anthrax Deaths

  IDSR Indicators
    

IDSR Dengue Total

  IDSR Indicators
    

IDSR Dengue Deaths

  IDSR Indicators
    

IDSR Guinea Worm Disease Total

  IDSR Indicators
    
    

IDSR Maternal deaths

  IDSR Indicators
    

IDSR Maternal deaths Deaths

  IDSR Indicators
    

IDSR Neonatal deaths Total

  IDSR Indicators
    

IDSR Neonatal deaths Deaths

  IDSR Indicators
    

IDSR Rabies Total

  IDSR Indicators
    

IDSR Rabies Deaths

  IDSR Indicators
    
    
    

IDSR Malaria Cases

  IDSR Indicators
    

IDSR Malaria Deaths

  IDSR Indicators
    

IDSR Typhoid Deaths

  IDSR Indicators
    

IDSR Dysentry Deaths

  IDSR Indicators
    

IDSR Measles Deaths

  IDSR Indicators
    
    
    
    
    
    

IDSR Dummy1

  IDSR Indicators
    

IDSR Dummy2

  IDSR Indicators
    

IDSR Malaria Positivity

  IDSR Indicators
    

Perinatal Deaths

  Safe Delivery
Total deaths within 7 days of births
    

% of Perinatal Deaths Audited

  Safe Delivery
Number of of perinatal deaths audited divided by total number of perinatal deaths reported via DHIS2
    

% of Perinatal Deaths Audited

  Integrated Scorecard
Number of of perinatal deaths audited divided by total number of perinatal deaths reported via DHIS2
    
    
    
    

Suspected Malaria cases tested

  Malaria
proportion of patients presenting with malaria symptoms (suspected malaria) subjected to a malaria Dx test (RDT or microscopy)
    

Suspected Malaria cases tested

  Malaria Scorecard Indicators
proportion of patients presenting with malaria symptoms (suspected malaria) subjected to a malaria Dx test (RDT or microscopy)
    
    
    
    
    
    

Propotional of ANC clients with Hb <11g/dl

  Nutrition Indicator Scorecard
    
    
    
    
    
    
    
    
    
    

Proportion of households visited (%)

  Scorecard Indicators
    

Proportion of households visited (%)

  Draft Kenya RMNCAH Scorecard
    

Total Suspected malaria cases (<5Years MoH 705A+>5Years MoH 705B)

  Malaria
Suspected malaria <5yrs ( MoH705A)+ Suspected malaria >5 yrs ( MoH705B)
    

Total Suspected malaria cases (<5Years MoH 705A+>5Years MoH 705B)

  Malaria Scorecard Indicators
Suspected malaria <5yrs ( MoH705A)+ Suspected malaria >5 yrs ( MoH705B)
    

Total Confirmed malaria cases (<5Years MoH 705A+>5Years MoH 705B)

  Malaria
Sum ofConfirmed malaria cases (<5Years MoH 705A+>5Years MoH 705B)
    

Total Confirmed malaria cases (<5Years MoH 705A+>5Years MoH 705B)

  Essential Services Indicators
Sum ofConfirmed malaria cases (<5Years MoH 705A+>5Years MoH 705B)
    
    
    
    
    

% of Patients treated with AL as a proportion of confirmed malaria cases.

  Malaria
Patients on AL by weight band summary (aggregate) from Malaria Commodities/ Confirmed malaria cases (aggregate) from MOH 705
    

% of Patients treated with AL as a proportion of confirmed malaria cases.

  Malaria Scorecard Indicators
Patients on AL by weight band summary (aggregate) from Malaria Commodities/ Confirmed malaria cases (aggregate) from MOH 705
    
    

Total Number of Confirmed Malaria cases- IDSR

  Malaria Scorecard Indicators
    
    
    
    
    
    
    
    
    
    
    

HV01-03 Total Tested

  HIV Care Global Indicators '17
HV01-03 Total Tested
    

HV01-01 First Testing

  HIV Care Global Indicators '17
    

HV01-02 Repeat Testing

  HIV Care Global Indicators '17
    

HV01-11 Positive| Females - Below 15 year

  HIV Care Global Indicators '17
    

HV01-10 Positive| Males - Below 15 year

  HIV Care Global Indicators '17
    

HV01-13 Positive Female 15-24 years

  HIV Care Global Indicators '17
    

HV01-15 Positive Females 25 years & older

  HIV Care Global Indicators '17
    

HV01-14 Positive Males 25 years & older

  HIV Care Global Indicators '17
    

HV01-12 Positive Males 15-24 years

  HIV Care Global Indicators '17
    

HV02-17 Total PMTCT prophylaxis

  HIV Care Global Indicators '17
    

HV02-13 Prophylaxis – NVP Only

  HIV Care Global Indicators '17
    

HV02-14 Prophylaxis – (AZT + SdNVP)

  HIV Care Global Indicators '17
    

HV02-15 Prophylaxis – Interrupted HAART

  HIV Care Global Indicators '17
    

HV02-16 HAART (ART)

  HIV Care Global Indicators '17
    

HV02-01 Testing for HIV Antenatal

  HIV Care Global Indicators '17
    

HV02-05 Known positive status (at entry into ANC)

  HIV Care Global Indicators '17
HV02-05
    

HV02-06 HIV positive results Antenatal

  HIV Care Global Indicators '17
    

HV03-36 Currently on ART - Below 15 years

  HIV Care Global Indicators '17
    

HV03-35 Currently on ART - Below 15 years

  HIV Care Global Indicators '17
    

HV03-38 Currently on ART - 15 years & older

  HIV Care Global Indicators '17
    

HV03-37 Currently on ART - 15 years & older

  HIV Care Global Indicators '17
    

HV03-22 (F) Starting ART - Below 15 years

  HIV Care Global Indicators '17
    

HV03-21 (M) Starting ART - Below 15 years

  HIV Care Global Indicators '17
    

HV03-24 (F) Starting ART - 15 years & older

  HIV Care Global Indicators '17
    

HV03-23 (M) Starting ART - 15 years & older

  HIV Care Global Indicators '17
    

Adolescent pregnancy

  Integrated Scorecard
    

Adolescent pregnancy

  Outcome Indicators
    
    
    
    
    

IDSR Total Malaria Cases

  IDSR Indicators
IDSR Total Malaria Cases
    

IDSR Total Malaria Tests Performed

  IDSR Indicators
IDSR Total Malaria Tests Performed
    
    
    

OTP Non Recovered - Nutrition

  Nutrition Indicators
    
    

SFP Death Rate - Nutrition PLW

  Nutrition Indicators
    

SFP Cure Rate Nutrition PLW

  Nutrition Indicators
    

SFP Default Rate Nutrition PLW

  Nutrition Indicators
    

SFP Non Recovered Rate PLW

  Nutrition Indicators
    

ALOS Out Patient Nutrition <5years

  Nutrition Indicators
    

ALOS Out Patient Nutrition <5years

  Nutrition Indicator Scorecard
    

ALOS Supplementary 6-59 months

  Nutrition Indicators
    

ALOS Supplimentary Nutrition PLW

  Nutrition Indicators
    

Stabilisation Centre total admissions

  Nutrition Indicators
    

OTP total admissions

  Nutrition Indicators
    

SFP total admissions

  Nutrition Indicators
    
    

KHIS_HTS_TST(<15-Male-Positive)

  KHIS Data Alignment
KHIS_HTS_TST(<15-Male-Positive)
    

KHIS_HTS_TST(<15-Female-Positive)

  KHIS Data Alignment
KHIS_HTS_TST(<15-Female-Positive)
    

KHIS_HTS_TST(<15-Unknown-Positive)

  KHIS Data Alignment
KHIS_HTS_TST(<15-Unknown-Positive)
    

KHIS_HTS_TST(>=15-Male-Positive)

  KHIS Data Alignment
KHIS_HTS_TST(>=15-Male-Positive)
    

KHIS_HTS_TST(>=15-Female-Positive)

  KHIS Data Alignment
KHIS_HTS_TST(>=15-Female-Positive)
    

KHIS_HTS_TST(Total-Unknown-Negative)

  KHIS Data Alignment
KHIS_HTS_TST(Total-Unknown-Negative)
    

KHIS_PMTCT_ART(N/A)

  KHIS Data Alignment
KHIS_PMTCT_ART(N/A)
    

KHIS_PMTCT_STAT

  KHIS Data Alignment
KHIS_PMTCT_STAT
    

KHIS_TX_CURR(<15-Male)

  KHIS Data Alignment
KHIS_TX_CURR(<15-Male)
    

KHIS_TX_CURR(<15-Female)

  KHIS Data Alignment
KHIS_TX_CURR(<15-Female)
    

KHIS_TX_CURR(<15-Unknown)

  KHIS Data Alignment
KHIS_TX_CURR(<15-Unknown)
    

KHIS_TX_CURR(>=15-Male)

  KHIS Data Alignment
KHIS_TX_CURR(>=15-Male)
    

KHIS_TX_CURR(>=15-Female)

  KHIS Data Alignment
KHIS_TX_CURR(>=15-Female)
    

KHIS_TX_NEW(<15-Male)

  KHIS Data Alignment
KHIS_TX_NEW(<15-Male)
    

KHIS_TX_NEW(<15-Female)

  KHIS Data Alignment
KHIS_TX_NEW(<15-Female)
    

KHIS_TX_NEW(<15-Unknown)

  KHIS Data Alignment
KHIS_TX_NEW(<15-Unknown)
    

KHIS_TX_NEW(>=15-Female)

  KHIS Data Alignment
KHIS_TX_NEW(>=15-Female)
    

KHIS_TX_NEW(>=15-Male)

  KHIS Data Alignment
KHIS_TX_NEW(>=15-Male)
    
    
    
    
    

OPD Total(New +Revisit)

  Out Patient
    

OPD Total(New +Revisit)

  Essential Services Indicators
    

(%) of pregnant women who are Adolescents (10-19 years)

  Antenatal
Adolescents (10-14yrs + 15-19yrs) presenting with pregnancy divide by total new ANC Clients
    

(%) of pregnant women who are Adolescents (10-19 years)

  Essential Services Indicators
Adolescents (10-14yrs + 15-19yrs) presenting with pregnancy divide by total new ANC Clients
    
    

Inpatient Admission

  Out Patient
    

Maternal Mortality ratio per 100,000

  Outcome Indicators
Maternal Mortality ratio per 100,000( (a direct measure of obstetric risk) Rate- Maternal deaths divided by the number of births and multiplied by 100,000)
    
    

MOS-MoH 730A Revision 2017 Adult preparations Abacavir/Lamivudine (ABC/3TC) 600mg/300mg FDCTablets 60s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Abacavir/Lamivudine (ABC/3TC) 600mg/300mg FDCTablets 60s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Abacavir/Lamivudine (ABC/3TC) 600mg/300mg FDCTablets 60s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Abacavir/Lamivudine (ABC/3TC) 120mg/60mg FDC Tablets 30s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparationsAbacavir/Lamivudine (ABC/3TC) 120mg/60mg FDC Tablets 30s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparationsAbacavir/Lamivudine (ABC/3TC) 120mg/60mg FDC Tablets 30s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Dolutegravir(DTG) 50mg tabs 30s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Dolutegravir(DTG) 50mg tabs 30s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Dolutegravir(DTG) 50mg tabs 30s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Efavirenz (EFV) 600mg Tablets 30s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Efavirenz (EFV) 600mg Tablets 30s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Efavirenz (EFV) 600mg Tablets 30s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Lamivudine (3TC) 150mg Tablets 60s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Lamivudine (3TC) 150mg Tablets 60s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Lamivudine (3TC) 150mg Tablets 60s QUANTITY ISSUED
    

MOH-729B Total Patient NO. on Adult ART 1st Line regimens

  MOH-729B Patient Summary
Total Patient Numbers on Adult ART 1st Line regimens
    

MOS-MoH 730A Revision 2017 Adult preparations Lopinavir/ritonavir (LPV/r) 200/50mg Tablets 120s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Lopinavir/ritonavir (LPV/r) 200/50mg Tablets 120s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Lopinavir/ritonavir (LPV/r) 200/50mg Tablets 120s QUANTITY ISSUED
    
    
    
    
    
    
    

MOS-MoH 730A Revision 2017 Adult preparations Nevirapine (NVP) 200mg Tablets 60s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Nevirapine (NVP) 200mg Tablets 60s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Nevirapine (NVP) 200mg Tablets 60s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Raltegravir (RAL) 400mg Tablets 60s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Raltegravir (RAL) 400mg Tablets 60s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Raltegravir (RAL) 400mg Tablets 60s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Tenofovir (TDF) 300mg Tablets 30s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Tenofovir (TDF) 300mg Tablets 30s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Tenofovir (TDF) 300mg Tablets 30s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Abacavir/Lamivudine (ABC/3TC) 120mg/60mg FDC Tablets 30s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparations Abacavir/Lamivudine (ABC/3TC) 120mg/60mg FDC Tablets 30s PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Abacavir/Lamivudine (ABC/3TC) 120mg/60mg FDC Tablets 30s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Tenofovir/Emtricitabine (TDF/FTC) FDC (300/200mg) Tablets 30s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Tenofovir/Emtricitabine (TDF/FTC) FDC (300/200mg) Tablets 30s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Tenofovir/Emtricitabine (TDF/FTC) FDC (300/200mg) Tablets 30s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Tenofovir/Lamivudine (TDF/3TC) FDC (300/300mg) Tablets 30s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Tenofovir/Lamivudine (TDF/3TC) FDC (300/300mg) Tablets 30s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Tenofovir/Lamivudine (TDF/3TC) FDC (300/300mg) Tablets 30s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/400mg) FDC Tablets 30s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations enofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/400mg) FDC Tablets 30s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations enofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/400mg) FDC Tablets 30s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Darunavir (DRV) 150mg Tablets 240s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparations Darunavir (DRV) 150mg Tablets 240s PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Darunavir (DRV) 150mg Tablets 240s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Darunavir (DRV) 75mg Tablets 480s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparations Darunavir (DRV) 75mg Tablets 480s PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Darunavir (DRV) 75mg Tablets 480s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Darunavir (DRV) susp 100mg/ml (200ml Bottles)

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparationsDarunavir (DRV) susp 100mg/ml (200ml Bottles) PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparationsDarunavir (DRV) susp 100mg/ml (200ml Bottles) QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/600mg) FDC Tablets 30s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/600mg) FDC Tablets 30s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) FDC (300/300/600mg) FDC Tablets 30s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Efavirenz (EFV) 200mg Tablets 90s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparations Efavirenz (EFV) 200mg Tablets 90s PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Efavirenz (EFV) 200mg Tablets 90s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Zidovudine (AZT) 300mg Tablets 60s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Zidovudine (AZT) 300mg Tablets 60s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Zidovudine (AZT) 300mg Tablets 60s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Zidovudine/Lamivudine (AZT/3TC) FDC (300/150mg) Tablets 60s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Zidovudine/Lamivudine (AZT/3TC) FDC (300/150mg) Tablets 60s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Zidovudine/Lamivudine (AZT/3TC) FDC (300/150mg) Tablets 60s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Efavirenz (EFV) 200mg Tablets 90s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparationsEfavirenz (EFV) 200mg Tablets 90sPHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Efavirenz (EFV) 200mg Tablets 90s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Etravirine (ETV) 100mg Tablets 60s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparations Etravirine (ETV) 100mg Tablets 60s PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Etravirine (ETV) 100mg Tablets 60s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Adult preparations Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (300/150/200mg) Tablets 60s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Adult preparations Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (300/150/200mg) Tablets 60s PHYSICAL COUNT divided by MoH 730B Revision 2017 Adult preparations Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (300/150/200mg) Tablets 60s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Lamivudine (3TC) liquid 10mg/ml (240ml Bottles)

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparations Lamivudine (3TC) liquid 10mg/ml (240ml Bottles) PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Lamivudine (3TC) liquid 10mg/ml (240ml Bottles)QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Lopinavir/ritonavir (LPV/r) 100/25mg Tabs 60s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparations Lopinavir/ritonavir (LPV/r) 100/25mg Tabs 60s PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Lopinavir/ritonavir (LPV/r) 100/25mg Tabs 60s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 TB/ HIV DRUGS Ethambutol 400mg Tab (for Pack of 28 tabs) 28s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 TB/ HIV DRUGS Ethambutol 400mg Tab (for Pack of 28 tabs) 28s PHYSICAL COUNT divided by MoH 730B Revision 2017 TB/ HIV DRUGS Ethambutol 400mg Tab (for Pack of 28 tabs) 28s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 TB/ HIV DRUGS Isoniazid (H) 100mg Tablets 100s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 TB/ HIV DRUGS TB/ HIV DRUGS Isoniazid (H) 100mg Tablets 100s PHYSICAL COUNT divided by MoH 730B Revision 2017 TB/ HIV DRUGS Isoniazid (H) 100mg Tablets 100s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Lopinavir/ritonavir (LPV/r) liquid 80/20mg/ml (60ml Bottles)

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparations Lopinavir/ritonavir (LPV/r) liquid 80/20mg/ml (60ml Bottles) PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Lopinavir/ritonavir (LPV/r) liquid 80/20mg/ml (60ml Bottles) QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 TB/ HIV DRUGS Isoniazid (H) 10mg/ml (120ml Bottles) 120ml Bottle

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 TB/ HIV DRUGS Isoniazid (H) 10mg/ml (120ml Bottles) 120ml Bottle PHYSICAL COUNT divided by MoH 730B Revision 2017 TB/ HIV DRUGS Isoniazid (H) 10mg/ml QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 TB/ HIV DRUGS Isoniazid (H) 300mg Tabs (for Pack of 100 tabs) 100s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 TB/ HIV DRUGS Isoniazid (H) 300mg Tabs (for Pack of 100 tabs) 100s PHYSICAL COUNT divided by MoH 730B Revision 2017 TB/ HIV DRUGS Isoniazid (H) 300mg Tabs (for Pack of 100 tabs) 100s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 TB/ HIV DRUGS Isoniazid (H) 300mg Tabs (for Pack of 672 tabs) 672s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 TB/ HIV DRUGS Isoniazid (H) 300mg Tabs (for Pack of 672 tabs) 672s PHYSICAL COUNT divided by MoH 730B Revision 2017 TB/ HIV DRUGS Isoniazid (H) 300mg Tabs (for Pack of 672 tabs) 672s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Nevirapine (NVP) Susp 10mg/ml (100 ml Bottles)

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparations Nevirapine (NVP) Susp 10mg/ml (100 ml Bottles) PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Nevirapine (NVP) Susp 10mg/ml (100 ml Bottles)QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 TB/ HIV DRUGS Pyrazinamide 500mg Tab (for Pack of 28 tabs) 28s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 TB/ HIV DRUGS Pyrazinamide 500mg Tab (for Pack of 28 tabs) 28s PHYSICAL COUNT divided by MoH 730B Revision 2017 TB/ HIV DRUGS Pyrazinamide 500mg Tab (for Pack of 28 tabs) 28s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 TB/ HIV DRUGS Pyridoxine 25mg Tabs 100s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 TB/ HIV DRUGS Pyridoxine 25mg Tabs 100s PHYSICAL COUNT divided by MoH 730B Revision 2017 TB/ HIV DRUGS Pyridoxine 25mg Tabs 100s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 TB/ HIV DRUGS Pyridoxine 50mg Tablets 100s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 TB/ HIV DRUGS Pyridoxine 50mg Tablets 100s PHYSICAL COUNT divided by MoH 730B Revision 2017 TB/ HIV DRUGS Pyridoxine 50mg Tablets 100s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 TB/ HIV DRUGS Rifabutin 150mg Tab 30s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 TB/ HIV DRUGS Rifabutin 150mg Tab 30s PHYSICAL COUNT divided by MoH 730B Revision 2017 TB/ HIV DRUGS Rifabutin 150mg Tab 30s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Ritonavir liquid 80mg/ml (90ml Bottles)

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparationsRitonavir liquid 80mg/ml (90ml Bottles) PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Ritonavir liquid 80mg/ml (90ml Bottles) QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Zidovudine (AZT) liquid 10mg/ml (240ml Bottles)

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparations Zidovudine (AZT) liquid 10mg/ml (240ml Bottles) PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Zidovudine (AZT) liquid 10mg/ml (240ml Bottles)QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Zidovudine/Lamivudine (AZT/3TC) FDC (60/30mg) Tablets 60s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparations Zidovudine/Lamivudine (AZT/3TC) FDC (60/30mg) Tablets 60s PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Zidovudine/Lamivudine (AZT/3TC) FDC (60/30mg) Tablets 60s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Paediatric preparations Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (60/30/50mg) Tablets 60s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Paediatric preparations Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (60/30/50mg) Tablets 60s PHYSICAL COUNT divided by MoH 730B Revision 2017 Paediatric preparations Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) FDC (60/30/50mg) Tablets 60s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Medicines for OIs Acyclovir 400mg Tablets 30s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Medicines for OIs Acyclovir 400mg Tablets 30s PHYSICAL COUNT divided by MoH 730B Revision 2017 Medicines for OIs Acyclovir 400mg Tablets 30s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Medicines for Ols Amphotericin B 50mg IV Injection 1vial

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Medicines for OIs Amphotericin B 50mg IV Injection 1vial PHYSICAL COUNT divided by MoH 730B Revision 2017 Medicines for OIs Amphotericin B 50mg IV Injection 1vial QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Medicines for OIs Cotrimoxazole 960mg Tablets 100s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Medicines for OIs Cotrimoxazole 960mg Tablets 100s PHYSICAL COUNT divided by MoH 730B Revision 2017 Medicines for OIs Cotrimoxazole 960mg Tablets 100s QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Medicines for OIs Cotrimoxazole suspension 240mg/5ml 100ml bottle

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Medicines for OIs Cotrimoxazole suspension 240mg/5ml 100ml bottle PHYSICAL COUNT divided by MoH 730B Revision 2017 Medicines for OIs Cotrimoxazole suspension 240mg/5ml 100ml bottle QUANTITY ISSUED
    

MOS-MoH 730A Revision 2017 Medicines for OIs Fluconazole 200mg Tablets 100s

  MOS-MoH 730A Revision 2017 commodities
MoH 730A +730B Revision 2017 Medicines for OIsFluconazole 200mg Tablets 100s PHYSICAL COUNT divided by MoH 730B Revision 2017 Medicines for OIs Fluconazole 200mg Tablets 100s QUANTITY ISSUED
    

MOH-729B Total Number Adult PEP

  MOH-729B Patient Summary
    

MOH-729B Total no. PEP for Adults

  MOH-729B Patient Summary
    

MOH-729B Total no.PEP for Children

  MOH-729B Patient Summary